Why Sequence My Antibody Protein?
Over the past decade of sequencing thousands of antibodies, we’ve discovered the top reasons to sequence your antibody protein.
Top reasons to sequence my antibody
1. To protect my intellectual property through patents for regulatory application and antibody production.
2. To secure my antibodies in case my hybridomas stop producing or my freezers fail. At Abterra Bio, we have worked on many projects over the years to rescue proteins for our clients. (or any biological failures). We can help you prepare for the worst by sequencing the hybridomas using next-generation sequencing , or help you recover from disaster by sequencing the antibody protein.
3. To ensure quality and consistency of my research. I can produce my antibody recombinantly once I have the sequence, ensuring the same antibody is produced in every batch.
Valens™ is a mass spectrometry-powered service to sequence and provide direct information about the antibody protein. We offer two services using Valens™; antibody protein sequencing to recover the full antibody sequence when no source cell is available and antibody sequence confirmation to determine if the produced antibody matches the intended gene sequence.
We summarized the methods for antibody protein sequencing in a related blog post.
Important considerations when choosing an antibody sequencing partner:
- Experience – we have over 10 years of antibody protein sequencing, and sequenced thousands of hybridomas, so we know how to sequence an antibody!
- Location – all work is performed in the US.
- Flexibility – we’ve sequenced samples with as little as 20 ug, low purity supernatant samples, and sample with conjugates.
Tell Us About Your Project
Related Posts
A Decade of De Novo Antibody Sequencing Experience
De novo antibody sequencing experience Have you lost your hybridoma? Is your hybridoma no longer producing? Is your hybridoma producing more than your desired antibody? Do you have a monoclonal antibody from a clinical sample, but no way to recover the source B cell?...
New Publication Reveals Ebolavirus-Neutralizing Monoclonal Antibodies
Abterra Biosciences, together with VUMC Vaccine Center, Mapp Bio, PNNL, UTMB Health, Ragon Institute, Integral Molecular, and La Jolla Institute, recently published a paper describing the discovery of Ebolavirus-neutralizing antibodies from convalescent plasma.Read...
Immune Repertoire Sequencing in Human
Immune repertoire sequencing enables deeper understanding of the adaptive immune response [1]. Abterra Biosciences has developed Reptor™, a flexible immune repertoire sequencing and analysis service. In this study, we analyzed the B-cell receptor (BCR) repertoire...